272 related articles for article (PubMed ID: 23480493)
21. In vitro activity of 20 agents in different prognostic subgroups of chronic lymphocytic leukemia--rolipram and prednisolone active in cells from patients with poor prognosis.
Lindhagen E; Norberg M; Kanduri M; Tobin G; Säisänen L; Aberg M; Gustafsson MG; Sundström C; Rosenquist R; Aleskog A
Eur J Haematol; 2009 Jul; 83(1):22-34. PubMed ID: 19245531
[TBL] [Abstract][Full Text] [Related]
22. LPL gene expression is associated with poor prognosis in CLL and closely related to NOTCH1 mutations.
Kristensen L; Kristensen T; Abildgaard N; Royo C; Frederiksen M; Mourits-Andersen T; Campo E; Møller MB
Eur J Haematol; 2016 Aug; 97(2):175-82. PubMed ID: 26558352
[TBL] [Abstract][Full Text] [Related]
23. New prognostic markers in CLL.
Montserrat E
Hematology Am Soc Hematol Educ Program; 2006; ():279-84. PubMed ID: 17124073
[TBL] [Abstract][Full Text] [Related]
24. Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: A comparison of cellular, cytogenetic, molecular, and clinical features.
Morabito F; Mosca L; Cutrona G; Agnelli L; Tuana G; Ferracin M; Zagatti B; Lionetti M; Fabris S; Maura F; Matis S; Gentile M; Vigna E; Colombo M; Massucco C; Recchia AG; Bossio S; De Stefano L; Ilariucci F; Musolino C; Molica S; Di Raimondo F; Cortelezzi A; Tassone P; Negrini M; Monti S; Rossi D; Gaidano G; Ferrarini M; Neri A
Clin Cancer Res; 2013 Nov; 19(21):5890-900. PubMed ID: 24036852
[TBL] [Abstract][Full Text] [Related]
25. Immunoglobulin gene rearrangements and mutational status in argentinian patients with chronic lymphocytic leukemia.
Stanganelli C; Travella A; Bezares R; Slavutsky I
Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):447-457.e2. PubMed ID: 23665144
[TBL] [Abstract][Full Text] [Related]
26. NOTCH1, SF3B1, BIRC3 and TP53 mutations in patients with chronic lymphocytic leukemia undergoing first-line treatment: correlation with biological parameters and response to treatment.
Chiaretti S; Marinelli M; Del Giudice I; Bonina S; Piciocchi A; Messina M; Vignetti M; Rossi D; Di Maio V; Mauro FR; Guarini A; Gaidano G; Foà R
Leuk Lymphoma; 2014 Dec; 55(12):2785-92. PubMed ID: 24597984
[TBL] [Abstract][Full Text] [Related]
27. B-cell chronic lymphocytic leukemia with aberrant CD8 expression: genetic and immunophenotypic analysis of prognostic factors.
Schroers R; Pukrop T; Dürig J; Haase D; Dührsen U; Trümper L; Griesinger F
Leuk Lymphoma; 2004 Aug; 45(8):1677-81. PubMed ID: 15370224
[TBL] [Abstract][Full Text] [Related]
28. Genomic imbalance defines three prognostic groups for risk stratification of patients with chronic lymphocytic leukemia.
Houldsworth J; Guttapalli A; Thodima V; Yan XJ; Mendiratta G; Zielonka T; Nanjangud G; Chen W; Patil S; Mato A; Brown JR; Rai K; Chiorazzi N; Chaganti RS
Leuk Lymphoma; 2014 Apr; 55(4):920-8. PubMed ID: 24047479
[TBL] [Abstract][Full Text] [Related]
29. The study of different chromosomal aberrations, CD38 and ZAP-70 in chronic lymphocytic leukemia patients.
Hassab AH; Elbordiny MM; Elghandour AH; Sorour AF; Swelem RS
Egypt J Immunol; 2011; 18(2):77-93. PubMed ID: 23082473
[TBL] [Abstract][Full Text] [Related]
30. Significance of zeta-associated protein (ZAP-70) and CD38 expression in chronic lymphocytic leukemia.
el-Sharnouby JA; el-Shakankiri AA; Hendy OM; Ahmed LM; Taha AM
Egypt J Immunol; 2006; 13(2):69-84. PubMed ID: 18689273
[TBL] [Abstract][Full Text] [Related]
31. New prognostic markers in chronic lymphocytic leukemia.
Moreno C; Montserrat E
Blood Rev; 2008 Jul; 22(4):211-9. PubMed ID: 18448218
[TBL] [Abstract][Full Text] [Related]
32. Genetics of chronic lymphocytic leukemia: genomic aberrations and V(H) gene mutation status in pathogenesis and clinical course.
Stilgenbauer S; Bullinger L; Lichter P; Döhner H;
Leukemia; 2002 Jun; 16(6):993-1007. PubMed ID: 12040431
[TBL] [Abstract][Full Text] [Related]
33. Prognostic markers in chronic lymphocytic leukaemia.
Hamblin TJ
Best Pract Res Clin Haematol; 2007 Sep; 20(3):455-68. PubMed ID: 17707833
[TBL] [Abstract][Full Text] [Related]
34. Prognostic usage of V(H) gene mutation status and its surrogate markers and the role of antigen selection in chronic lymphocytic leukemia.
Tobin G; Rosenquist R
Med Oncol; 2005; 22(3):217-28. PubMed ID: 16110132
[TBL] [Abstract][Full Text] [Related]
35. Clinical and laboratory prognostic indicators in chronic lymphocytic leukemia.
Sagatys EM; Zhang L
Cancer Control; 2012 Jan; 19(1):18-25. PubMed ID: 22143059
[TBL] [Abstract][Full Text] [Related]
36. Major prognostic value of complex karyotype in addition to TP53 and IGHV mutational status in first-line chronic lymphocytic leukemia.
Le Bris Y; Struski S; Guièze R; Rouvellat C; Prade N; Troussard X; Tournilhac O; Béné MC; Delabesse E; Ysebaert L
Hematol Oncol; 2017 Dec; 35(4):664-670. PubMed ID: 27678008
[TBL] [Abstract][Full Text] [Related]
37. [News in therapeutic management of chronic lymphoid leukemia].
Michallet AS; Salles G; Coiffier B; Michallet M
Bull Cancer; 2005 Mar; 92(3):249-56. PubMed ID: 15820919
[TBL] [Abstract][Full Text] [Related]
38. Prognostic Factors in the Era of Targeted Therapies in CLL.
Boddu P; Ferrajoli A
Curr Hematol Malig Rep; 2018 Apr; 13(2):78-90. PubMed ID: 29473123
[TBL] [Abstract][Full Text] [Related]
39. Genomic data integration in chronic lymphocytic leukemia.
Fernández-Martínez JL; deAndrés-Galiana EJ; Sonis ST
J Gene Med; 2017 Jan; 19(1-2):. PubMed ID: 27928896
[TBL] [Abstract][Full Text] [Related]
40. Novel prognostic molecular factors: a quantum leap in the field of chronic lymphocytic leukemia.
Zakrzewska E; Pirog M; Purkot J; Giannopoulos K
Folia Histochem Cytobiol; 2017; 55(3):95-106. PubMed ID: 28994094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]